Pharma’s lobbying efforts: 10 drugmakers that spent the most so far in 2017

(By Alia Paavola for Becker’s Hospital Review)

Pharmaceutical and medical device companies have collectively spent $208 million on lobbying efforts so far in 2017, according to data from the Center for Responsive Politics, a nonprofit, nonpartisan research group based in Washington D.C. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.